Novartis | NVS - PE Price to Earnings

Stock Price
152.91
Daily Change
3.12 2.08%
Monthly
10.91%
Yearly
39.25%
Q1 Forecast
145.07

Novartis reported $16.05 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 110.26 91.85 Sep/2025
Amgen USD 9.49 3.02 Sep/2025
AstraZeneca USD 21.49 1.46 Sep/2025
Bausch Health Companies USD 6.57 4.8 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
Bristol-Myers Squibb USD 8.24 9.03 Sep/2025
Corcept Therapeutics USD 94.18 30.36 Sep/2025
Drreddys Laboratories INR 18.27 0.84 Dec/2025
Eli Lilly USD 49.87 12.87 Sep/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
GlaxoSmithKline GBP 11.44 6.82 Sep/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
J&J USD 23.62 0.86 Dec/2025
Merck USD 8.84 0.26 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Novartis USD 16.05 2.92 Sep/2025
Pacira USD 29.24 6.15 Sep/2025
Perrigo USD 34.31 15.46 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Prestige Brands USD 12.2 4.44 Sep/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
Sanofi EUR 15.75 1.53 Dec/2025
Supernus Pharmaceuticals USD 39.11 17.08 Sep/2025
Zoetis USD 23.26 2.68 Sep/2025